Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Novo Seeds co-leads EUR 37m investment in Camel-IDS
November 15, 2018

Novo Seeds has co-leaded an EUR 37m investment in Belgium-based biotechnology company Camel-IDS. Camel-IDS is a spin-off from Vrije Universiteit Brussel (VUB). Camel-IDS develops cancer-targeted radiopharmaceuticals based on single domain antibody fragments.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: